Aquestive Therapeutics
AQST
AQST
47 hedge funds and large institutions have $21.5M invested in Aquestive Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-7
Holders Change %
-12.96%
% of All Funds
0.75%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
6
Increased
12
Reduced
13
Closed
13
Calls
$286K
Puts
$37K
Net Calls
+$249K
Net Calls Change
+$88K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$5.57M |
| 2 |
Corient Private Wealth
Miami,
Florida
|
+$700K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$593K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$213K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$133K |
Top Sellers
| 1 |
Walleye Capital
New York
|
-$380K |
| 2 |
Man Group
London,
United Kingdom
|
-$212K |
| 3 |
Millennium Management
New York
|
-$200K |
| 4 |
Renaissance Technologies
New York
|
-$155K |
| 5 |
Two Sigma Investments
New York
|
-$140K |
